New York Senate Bill J00951

New York 2025-2026 Regular Session

• Introduced: 5/8/25
• Refer: 5/8/25
• Report Pass: 5/13/25
• Passed: 5/13/25

Caption

Memorializing Governor Kathy Hochul to proclaim May 11-17, 2025, as Fibromyalgia Awareness Week in the State of New York

Impact

The bill underscores the urgent need for increased education about Fibromyalgia both within the medical community and the general public. It addresses the damaging effects of the condition, including job loss, social isolation, and mental health issues like anxiety and depression. By designating a specific week for awareness, the resolution aims to foster a better understanding of Fibromyalgia, promote more research funding, and support efforts to improve diagnosis and treatment options for patients affected by the condition.

Summary

Bill J00951 is a legislative resolution that memorializes Governor Kathy Hochul to proclaim the week of May 11-17, 2025, as Fibromyalgia Awareness Week in the State of New York. The resolution recognizes the impact of Fibromyalgia, a chronic syndrome characterized by widespread pain and fatigue, which affects an estimated 10 million people in the U.S. and a significant percentage of the global population. The bill aims to enhance awareness and understanding of Fibromyalgia while drawing attention to the challenges faced by those living with the condition.

Sentiment

The sentiment surrounding Bill J00951 is largely positive, as it is viewed as a necessary step toward advocating for those suffering from Fibromyalgia. Legislators and advocacy groups have expressed support for increased awareness, emphasizing the importance of educating medical professionals about the complexities of the syndrome. The resolution is seen as an opportunity to spotlight both the struggles faced by patients and the need for comprehensive support systems in healthcare and employment.

Contention

While the bill has garnered broad support, some contention might arise from budget considerations related to public awareness campaigns and educational initiatives. Additionally, there may be discussions regarding how effectively the awareness week can translate into tangible improvements for patients, particularly in areas like healthcare provisions and legislative protections. Overall, the main contention lies not within the resolution itself, but rather in how to best address the systemic issues faced by Fibromyalgia patients beyond the scope of a designated awareness week.